BRELIANT
LIVE

Serial Number

79237243

Owner

NOVARTIS AG

Filing Date

Feb 13, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BRELIANT Trademark

Serial Number: 79237243 • Registration: 5614199

BRELIANT is a trademark filed by NOVARTIS AG on February 13, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 13, 2018

Registration Date

November 27, 2018

Published for Opposition

September 11, 2018

Cancellation Date

June 13, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 13, 2026 INTR
CANCELLED SECTION 71
Jun 13, 2025 C71T
NOTIFICATION PROCESSED BY IB
Jan 25, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 10, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 10, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 27, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 27, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Sep 21, 2018 GPNX
PUBLISHED FOR OPPOSITION
Sep 11, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 5, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 5, 2018 OP2R
NOTICE OF PUBLICATION
Aug 22, 2018 NPUB
APPLICATION FILING RECEIPT MAILED
Aug 7, 2018 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2018 CNSA
ASSIGNED TO EXAMINER
Aug 2, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 1, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 26, 2018 REPR